Anaplastic Astrocytoma - 215 Studies Found
Completed |
: Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma : Anaplastic Astrocytoma : 1999-11-01 : Drug: Antineoplaston therapy (Atengenal + Astugenal) Adult |
Completed |
: Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma : Glioblastoma Multiforme/Anaplastic Astrocytoma : 2009-02-10 :
|
Completed |
: Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma :
: 2006-03-09 : Drug: Erlotinib Tarceva®: Will be given at a starting dose of 150mg QD dose for the first cycle whi |
Terminated |
: Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma :
: 2008-09-26 :
|
Completed |
: A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma :
: 2008-01-21 : Drug: Sunitinib Malate Initially, patients were started on sunitinib at a dose of 50 mg daily. If 50 mg |
Suspended |
: Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma :
: 2011-06-13 :
|
Recruiting |
: Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients :
|
Completed |
: BNCT to Treat Glioma That Has Progressed Following Radiotherapy :
: 2005-06-22 : Radiation: Bononophenylalanine (BPA)-based BNCT Boronophenylalanine is infused into a peripheral vein pr |
Recruiting |
: Immunophenotyping From Blood of Patients With Malignant Gliomas :
: 2013-12-13 : Other: Blood sample and life quality questionnaires Blood will be drawn at distinct time points during a |
Active, not recruiting |
: Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA :
: 2010-08-10 : Drug: Super-Selective Intraarterial Intracranial Infusion of Temozolomide A single dose of Intraarterial |